Compare MAPP to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 9.05 |
|---|---|
| Trade Time: | Nov 30 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 9.05 |
| Open: | N/A |
| Bid: | N/A |
| Ask: | 9.23 x 500 |
| 1y Target Est: | 13.40 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 1.57 - 13.85 |
| Volume: | 0 |
| Avg Vol (3m): | 115,802 |
| Market Cap: | 221.67M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.82 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 12 | MAP Pharmaceuticals gets $60M financing facilityAP |
| Thu, Nov 12 | MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExEDGAR Online |
| Thu, Nov 12 | MAP Pharmaceuticals Secures $60 Million Committed Equity Financing FacilityPR Newswire |
| Wed, Nov 11 | MAP PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials |
| Wed, Nov 11 | MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare ConferencePR Newswire |
| Sun, Nov 8 | New Star Analyst Rankings for MAP Pharmaceuticals, Inc.StarMine |
| Fri, Nov 6 | MAP PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Thu, Nov 5 | MAP Pharmaceuticals goes from Q3 loss to $19.3M profitat bizjournals.com |
| Thu, Nov 5 | MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online |
| Thu, Nov 5 | MAP Pharmaceuticals Reports Third Quarter of 2009 Financial ResultsPR Newswire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.